![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 5, 3561-3567, February 4, 2000
§¶,
§¶,
,
,
§¶, and
§¶§§
From the We have identified previously a novel complex
mutant allele in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene in a patient affected with cystic
fibrosis (CF). This allele contained a mutation in CFTR
exon 11 known to cause CF (S549R(T>G)), associated with the first
alteration described so far in the minimal CFTR promoter
region (
Laboratoire de Génétique
Moléculaire, Centre Spitalier Universitaire, and the

Laboratoire de Virologie Moléculaire,
§ Institut de Biologie, 34060 Montpellier and the
Laboratoire de Biologie des Encéphalopathies Spongiformes
Transmissibles and the ** Laboratoire de Virologie Moléculaire et
Transfert de Gènes, ¶ CNRS Institut de Génétique
Humaine Unité Propre de Recherche 1142, 34396 Montpellier Cedex 5, France
102T>A). Studies on genotype-phenotype correlations revealed
striking differences between patients carrying mutation (S549R(T>G))
alone, who had a severe disease, and patients carrying the complex
allele (
102(T>A)+S549R(T>G)), who exhibited milder forms of CF. We
thus postulated that the sequence change (
102T>A) may attenuate the
effects of the severe (S549R(T>G)) mutation through regulation of CFTR
expression. Analysis of transiently transfected cell lines with
wild-type and
102A variant human CFTR-directed luciferase
reporter genes demonstrates that constructs containing the
102A
variant (which creates a Yin Yang 1 (YY1) core element) increases CFTR
expression significantly. Electrophoretic mobility shift assays
indicate that the
102 site is located in a region of multiple
DNA-protein interactions and that the
102A allele recruits
specifically an additional nuclear protein related to YY1. The finding
that the YY1-binding allele causes a significant increase in CFTR
expression in vitro may allow a better understanding of the
milder phenotype observed in patients who carry a severe CF mutation
within the same gene.
This article has been cited by other articles:
![]() |
R. D. Houston, C. S. Haley, A. L. Archibald, N. D. Cameron, G. S. Plastow, and K. A. Rance A Polymorphism in the 5'-Untranslated Region of the Porcine Cholecystokinin Type A Receptor Gene Affects Feed Intake and Growth Genetics, November 1, 2006; 174(3): 1555 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rene, M. Taulan, F. Iral, J. Doudement, A. L'Honore, C. Gerbon, J. Demaille, M. Claustres, and M.-C. Romey Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway Nucleic Acids Res., September 16, 2005; 33(16): 5271 - 5290. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Ulatowski, K. L. Whitmore, T. Romigh, A. S. VanderWyden, S. M. Satinover, and M. L. Drumm Strain-specific variants of the mouse Cftr promoter region reveal transcriptional regulatory elements Hum. Mol. Genet., September 1, 2004; 13(17): 1933 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wray, M. W. Hahn, E. Abouheif, J. P. Balhoff, M. Pizer, M. V. Rockman, and L. A. Romano The Evolution of Transcriptional Regulation in Eukaryotes Mol. Biol. Evol., September 1, 2003; 20(9): 1377 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Muller, J. G. J. Hoenderop, R. Vennekens, P. Eggert, F. Harangi, K. Mehes, V. Garcia-Nieto, F. Claverie-Martin, C. H. v. Os, B. Nilius, et al. Epithelial Ca2+ channel (ECAC1) in autosomal dominant idiopathic hypercalciuria Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1614 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Tan, K. Nonaka, G. H. Nuckolls, Y. H. Liu, R. E. Maxson, H. C. Slavkin, and L. Shum YY1 activates Msx2 gene independent of bone morphogenetic protein signaling Nucleic Acids Res., March 1, 2002; 30(5): 1213 - 1223. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |